RxDoctor Payments Data

Michael Martin, MD

Family Medicine · Millersport, OHNPI 1083662951

Payments from drug & device makers

$451in general payments, 2019–2025

Across 26 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$203
  • GSK$89
  • Novo Nordisk$74
  • Corcept Therapeutics$21
  • Astellas Pharma US Inc$19
  • Takeda Pharmaceuticals U.S.A., Inc.$19
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$43997%
  • Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$451 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$156,444
Medicare patients
257
Services billed
2,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin177$192,038
EliquisApixaban170$166,293
OzempicSemaglutide78$113,829
Trelegy ElliptaFluticasone/Umeclidin/Vilanter81$84,790
XareltoRivaroxaban97$68,399
RybelsusSemaglutide24$54,154
FarxigaDapagliflozin Propanediol23$23,822
JanuviaSitagliptin Phosphate28$19,518
TradjentaLinagliptin13$19,261
Breo ElliptaFluticasone/Vilanterol31$17,732
LinzessLinaclotide13$16,580
Lantus SolostarInsulin Glargine,hum.Rec.Anlog117$16,226
Tresiba Flextouch U-100Insulin Degludec18$11,697
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$11,293
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$8,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$74$167,983102 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$89$111,349123 claims
AbbVieLinzess$203$16,58013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Millersport

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →